Loading
TI
Theratechnologies Inc. Stock: price and insider trades · Canada
Theratechnologies Inc.: what insiders have been doing
Every trade that managers of Theratechnologies Inc. disclose to SEDI is tracked on this page. The past year has been quiet: not a single insider filing for Theratechnologies Inc. The previous disclosure was published on 29 September 2025.
The full history, which starts in 2016, counts 129 purchases against 109 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
310
Thresholds
n/a
Buy Volume
€1M
129 ops. · all time
Sell Volume
€2M
109 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 29 September 2025
Declarations310 total
14,824 shares@ CA$3.020.1% of flowCommon SharesTSXSEDI:4580914
2,768 shares@ CA$3.01100.0% of flowCommon SharesTSXSEDI:4580899
8,307 sharesCommon SharesTSXSEDI:4390478
44,473 sharesCommon SharesTSXSEDI:4204957
23,880 sharesCommon SharesTSXSEDI:4204385
36,200 shares@ CA$1.3822.5% of flowCommon SharesTSXSEDI:4204386
Canonical exit: 30 Jan 2024 (T+90)
25,000 sharesCommon SharesTSXSEDI:4202373
Canonical exit: 30 Jan 2024 (T+90)
25,000 sharesCommon SharesTSXSEDI:4202369
Canonical exit: 29 Jan 2024 (T+90)
29,250 sharesCommon SharesTSXSEDI:4202366
23,250 sharesCommon SharesTSXSEDI:4200955
3,000 sharesCommon SharesTSXSEDI:4201165
242,700 sharesCommon SharesTSXSEDI:4201141
22,500 sharesCommon SharesTSXSEDI:4201147
83,400 sharesCommon SharesTSXSEDI:4201104
72,001 sharesCommon SharesTSXSEDI:4201164
13,700 shares@ CA$1.397.7% of flowCommon SharesTSXSEDI:4201151
Canonical exit: 25 Jan 2024 (T+90)
36,700 shares@ CA$1.3720.2% of flowCommon SharesTSXSEDI:4201153
Canonical exit: 25 Jan 2024 (T+90)
4,200 shares@ CA$1.382.3% of flowCommon SharesTSXSEDI:4201152
Canonical exit: 25 Jan 2024 (T+90)
68,900 shares@ CA$1.4239.3% of flowCommon SharesTSXSEDI:4201148
Canonical exit: 25 Jan 2024 (T+90)
8,000 shares@ CA$1.356911.5% of flowCommon SharesTSXSEDI:4200904
Canonical exit: 25 Jan 2024 (T+90)
45,000 shares@ CA$1.3626.9% of flowCommon SharesTSXSEDI:4201105
Canonical exit: 25 Jan 2024 (T+90)
15,800 shares@ CA$1.377.7% of flowCommon SharesTSXSEDI:4201144
Canonical exit: 25 Jan 2024 (T+90)
400 shares@ CA$1.3650.2% of flowCommon SharesTSXSEDI:4201143
Canonical exit: 25 Jan 2024 (T+90)
4,400 shares@ CA$1.402.5% of flowCommon SharesTSXSEDI:4201150
Canonical exit: 25 Jan 2024 (T+90)
2,100 shares@ CA$1.411.2% of flowCommon SharesTSXSEDI:4201149
Canonical exit: 25 Jan 2024 (T+90)
25 of 310 declarations
About Theratechnologies Inc.
Theratechnologies Inc. is a Canadian biopharmaceutical company focused on developing treatments for endocrine diseases and cancers. It emphasizes innovation in the field of hormonal therapies.
